Daniel M. Spevack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel M. Spevack has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Itzhak Kronzon
Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York
10 shared publicationsPaul A. Tunick
Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York
8 shared publicationsRobert J. Ostfeld
8 shared publicationsSanjay Doddamani
8 shared publicationsAlan Shah
New York University Medical Center, New York University School of Medicine, New York, New York
7 shared publicationsDivya Malhotra
Department of Cardiology Westchester Medical Center Valhalla New York USA
7 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (9)
Percutaneous Mechanical Aspiration of Left-Sided Intracardiac Masses for Prohibitive Surgical Candidates: A Single-Center Experience
- 28 July 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (9)
Open AccessPercutaneous Mechanical Aspiration of Left-Sided Intracardiac Masses for Prohibitive Surgical Candidates: A Single-Center Experience
- Open Access
- 22 January 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 630-634
Recurrent Infective Endocarditis With Recurrent Intravenous Drug Use: Illustrating the High Complexity of Surgical Decision-Making
- 22 January 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 630-634
Open AccessRecurrent Infective Endocarditis With Recurrent Intravenous Drug Use: Illustrating the High Complexity of Surgical Decision-Making
- 22 September 2025
- Published by Wiley in Echocardiography
- Vol. 42 (9) , e70299
Inclusion of the Right Ventricular Muscle Bundle During Interventricular Septal Measurement Improves Diagnostic Accuracy for Hypertrophic Cardiomyopathy
Introduction: Measurement of the interventricular septum (IVS) is a key diagnostic and prognostic parameter in the evaluation of hypertrophic cardiomyopathy (HCM). Right ventricular muscle bundles (RVMB) that parallel the IVS complicate septal measurement on both echocardiography and magnetic resonance imaging. Current guideline statements reference left ventricular wall thickness measurements greater than or equal to 15 mm as part of the diagnostic criteria for HCM. The medical literature lacks published data on the impact of including RVMB as part of the IVS measurement and its influence on diagnostic accuracy for HCM.Methods: We measured the IVS and RVMB separately on echocardiography in 97 consecutive subjects referred for both echocardiography and magnetic resonance imaging (MRI) as part of the initial evaluation for HCM. Subjects were categorized as having or not having HCM based on current practice guidelines. Patients with HCM were sub‐categorized as having septal involvement (HCM‐Sep) or primarily apical hypertrophy (HCM‐Ap). This was done because subjects with obvious HCM‐Ap could be diagnosed with HCM irrespective of IVS thickness.Results: Compared to subjects who did not have HCM, those with HCM‐Sep had both increased IVS (15.4 ± 2.7 vs. 9.8 ± 1.9 mm, p < 0.001) and RVMB thickness (5.2 ± 3.1 vs. 1.9 ± 1.9 mm, p < 0.001). In the whole study group, the area under the receiver operating characteristic (ROC) curve for HCM was higher (0.83 [95% confidence interval (CI): 0.75, 0.91]) when the RVMB was included in the IVS measurement compared to when it was excluded (0.75 [95% CI: 0.68, 0.81]). When the subjects with HCM‐Ap were excluded, the area under the ROC curve for HCM was higher (0.94 [95% CI: 0.89, 0.99]) when the RVMB was included in the IVS measurement compared to when it was excluded (0.82 [95% CI: 0.75, 0.89]). The number of subjects classified correctly for HCM improved from 78% to 94% when the RVMB was included.Conclusions: Inclusion of the RVMB in the measurement of IVS thickness on echocardiography may improve overall diagnostic accuracy for HCM. In addition, RVMB thickness is increased and is more often visible on parasternal long‐axis imaging in subjects with HCM, consistent with being part of the HCM pathology. This is particularly true in those with HCM‐Sep. These data have implications for the standardization of echocardiographic and MRI reporting in HCM.
- 22 September 2025
- Published by Wiley in Echocardiography
- Vol. 42 (9) , e70299
Inclusion of the Right Ventricular Muscle Bundle During Interventricular Septal Measurement Improves Diagnostic Accuracy for Hypertrophic Cardiomyopathy
Introduction: Measurement of the interventricular septum (IVS) is a key diagnostic and prognostic parameter in the evaluation of hypertrophic cardiomyopathy (HCM). Right ventricular muscle bundles (RVMB) that parallel the IVS complicate septal measurement on both echocardiography and magnetic resonance imaging. Current guideline statements reference left ventricular wall thickness measurements greater than or equal to 15 mm as part of the diagnostic criteria for HCM. The medical literature lacks published data on the impact of including RVMB as part of the IVS measurement and its influence on diagnostic accuracy for HCM.Methods: We measured the IVS and RVMB separately on echocardiography in 97 consecutive subjects referred for both echocardiography and magnetic resonance imaging (MRI) as part of the initial evaluation for HCM. Subjects were categorized as having or not having HCM based on current practice guidelines. Patients with HCM were sub‐categorized as having septal involvement (HCM‐Sep) or primarily apical hypertrophy (HCM‐Ap). This was done because subjects with obvious HCM‐Ap could be diagnosed with HCM irrespective of IVS thickness.Results: Compared to subjects who did not have HCM, those with HCM‐Sep had both increased IVS (15.4 ± 2.7 vs. 9.8 ± 1.9 mm, p < 0.001) and RVMB thickness (5.2 ± 3.1 vs. 1.9 ± 1.9 mm, p < 0.001). In the whole study group, the area under the receiver operating characteristic (ROC) curve for HCM was higher (0.83 [95% confidence interval (CI): 0.75, 0.91]) when the RVMB was included in the IVS measurement compared to when it was excluded (0.75 [95% CI: 0.68, 0.81]). When the subjects with HCM‐Ap were excluded, the area under the ROC curve for HCM was higher (0.94 [95% CI: 0.89, 0.99]) when the RVMB was included in the IVS measurement compared to when it was excluded (0.82 [95% CI: 0.75, 0.89]). The number of subjects classified correctly for HCM improved from 78% to 94% when the RVMB was included.Conclusions: Inclusion of the RVMB in the measurement of IVS thickness on echocardiography may improve overall diagnostic accuracy for HCM. In addition, RVMB thickness is increased and is more often visible on parasternal long‐axis imaging in subjects with HCM, consistent with being part of the HCM pathology. This is particularly true in those with HCM‐Sep. These data have implications for the standardization of echocardiographic and MRI reporting in HCM.
- Open Access
Inclusion of the right ventricular muscle bundle during interventricular septal measurement improves diagnostic accuracy for hypertrophic cardiomyopathy
Introduction Measurement of the interventricular septum (IVS) is a key diagnostic and prognostic parameter in the evaluation of hypertrophic cardiomyopathy (HCM). Right ventricular muscle bundles (RVMB) that parallel the IVS complicate septal measurement on both echocardiography and magnetic resonance imaging. Current guideline statements reference left ventricular wall thickness measurements more than 15 mm as part of the diagnostic criteria for HCM. The medical literature lacks published data on the impact of including RVMB as part of the IVS measurement and its influence on diagnostic accuracy for HCM. Methods We measured the IVS and RVMB separately on echocardiography in 97 consecutive subjects referred for both echocardiography and magnetic resonance imaging (MRI) as part of the initial evaluation for HCM. Subjects were categorized as having or not having HCM based on current practice guidelines. Patients with HCM were sub-categorized as having septal involvement (HCM-Sep) or primarily apical hypertrophy (HCM-Ap). This was done because subjects with obvious HCM-Ap could be diagnosed with HCM irrespective of IVS thickness. Results Compared to subjects who did not have HCM, those with HCM-Sep had both increased IVS (15.4 ± 2.7 vs 9.8 ± 1.9 mm, pConclusions Inclusion of the RVMB in the measurement of IVS thickness on echocardiography may improve overall diagnostic accuracy for HCM. In addition, RVMB thickness is increased and is more often visible on parasternal long axis imaging in subjects with HCM, consistent with being part of the HCM pathology. This is particularly true in those with HCM-Sep. These data have implications for standardization of echocardiographic and MRI reporting in HCM.
Open AccessInclusion of the right ventricular muscle bundle during interventricular septal measurement improves diagnostic accuracy for hypertrophic cardiomyopathy
Introduction Measurement of the interventricular septum (IVS) is a key diagnostic and prognostic parameter in the evaluation of hypertrophic cardiomyopathy (HCM). Right ventricular muscle bundles (RVMB) that parallel the IVS complicate septal measurement on both echocardiography and magnetic resonance imaging. Current guideline statements reference left ventricular wall thickness measurements more than 15 mm as part of the diagnostic criteria for HCM. The medical literature lacks published data on the impact of including RVMB as part of the IVS measurement and its influence on diagnostic accuracy for HCM. Methods We measured the IVS and RVMB separately on echocardiography in 97 consecutive subjects referred for both echocardiography and magnetic resonance imaging (MRI) as part of the initial evaluation for HCM. Subjects were categorized as having or not having HCM based on current practice guidelines. Patients with HCM were sub-categorized as having septal involvement (HCM-Sep) or primarily apical hypertrophy (HCM-Ap). This was done because subjects with obvious HCM-Ap could be diagnosed with HCM irrespective of IVS thickness. Results Compared to subjects who did not have HCM, those with HCM-Sep had both increased IVS (15.4 ± 2.7 vs 9.8 ± 1.9 mm, pConclusions Inclusion of the RVMB in the measurement of IVS thickness on echocardiography may improve overall diagnostic accuracy for HCM. In addition, RVMB thickness is increased and is more often visible on parasternal long axis imaging in subjects with HCM, consistent with being part of the HCM pathology. This is particularly true in those with HCM-Sep. These data have implications for standardization of echocardiographic and MRI reporting in HCM.
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Right ventricular and left ventricular diameters are independent predictors of death or cardiopulmonary resuscitation in intermediate and high-risk pulmonary embolisms
Background: Increased right ventricular (RV) dilation measured by the ratio of RV diameter (RVD) to left ventricular (LV) diameter (LVD) (RV:LV) is associated with pulmonary embolism (PE) severity and mortality. Data regarding the individual contributions of RVD and LVD are limited. Purpose: To examine RVD and LVD as independent contributors to death or need for cardiopulmonary resuscitation (CPR) in intermediate- or high-risk PEs treated with surgical or catheter-based strategies Methods: We measured basal RVD and LVD on presenting transthoracic echocardiograms (TTE) using the diastolic 4-chamber view on 127 PEs managed with surgical embolectomy (n=95, 75%), extracorporeal membrane oxygenation (n=23, 18%), or catheter-directed embolectomy (n=9, 7%) for intermediate- (64%) or high-risk (36%) PE (based on European Society of Cardiology criteria) between 2005 and 2022. The primary outcome was the composite of death (n=2) or survivors requiring CPR (n=10). Results: A total of 127 patients were analyzed. Subjects were 57±14 years, 38% women, BMI 34±8. Mean RVD and LVD were 4.4±0.9 cm and 3.9±0.8 cm respectively. All presented with severe RV dysfunction on TTE and elevated cardiac biomarkers (Troponin-I or B-type natriuretic peptide). Mean RV:LV was 1.2±0.3 (range 0.7 to 2.8). Using logistic regression, higher RV:LV was associated with increased odds of death or CPR (odds ratio (OR) 15 [95% confidence interval (CI): 2.5, 82] per 1-unit increase, p=0.002. RV:LV >1.2 was the cutoff most associated with death or CPR, OR 7.2 [95% CI: 1.5, 34.5], p=0.01. Increasing RVD [OR 3.8 (95% CI: 1.1, 12.8), p=0.03] and decreasing LVD [OR 4.9 (95% CI: 1.3, 16.9), p=0.02] were independent predictors of death or CPR. RVD >5.0 cm (OR 5.9 [95% CI: 1,5, 23.2], p 0.01) and LVD <3.6 cm (OR 7.0 [95% CI: 1.7, 27.9], p=0.006) were the cutoff values most associated with the primary outcome. These cutoff values remained significant predictors even after adjustment for body surface area. Other parameters or RV size and function (diastolic area, systolic area and fractional area change) did not predict death or CPR. All of the subjects meeting the primary outcome had high-risk PE. Discussion: In addition to RV:LV greater than 1.2, RVD and LVD were independently associated with death or CPR among high- or intermediate risk PEs. The independent contribution of declining LVD on PE mortality is a novel finding and highlights PE associatient LV pathophysiology (hyperdynamic and underfilled) antecedent to hemodynamic collapse. PE literature focuses on RV dilation as a predictor of PE mortality. LVD may represent a useful measure to risk stratify PE patients and predict hemodynamic decompensation. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Open AccessRight ventricular and left ventricular diameters are independent predictors of death or cardiopulmonary resuscitation in intermediate and high-risk pulmonary embolisms
Background: Increased right ventricular (RV) dilation measured by the ratio of RV diameter (RVD) to left ventricular (LV) diameter (LVD) (RV:LV) is associated with pulmonary embolism (PE) severity and mortality. Data regarding the individual contributions of RVD and LVD are limited. Purpose: To examine RVD and LVD as independent contributors to death or need for cardiopulmonary resuscitation (CPR) in intermediate- or high-risk PEs treated with surgical or catheter-based strategies Methods: We measured basal RVD and LVD on presenting transthoracic echocardiograms (TTE) using the diastolic 4-chamber view on 127 PEs managed with surgical embolectomy (n=95, 75%), extracorporeal membrane oxygenation (n=23, 18%), or catheter-directed embolectomy (n=9, 7%) for intermediate- (64%) or high-risk (36%) PE (based on European Society of Cardiology criteria) between 2005 and 2022. The primary outcome was the composite of death (n=2) or survivors requiring CPR (n=10). Results: A total of 127 patients were analyzed. Subjects were 57±14 years, 38% women, BMI 34±8. Mean RVD and LVD were 4.4±0.9 cm and 3.9±0.8 cm respectively. All presented with severe RV dysfunction on TTE and elevated cardiac biomarkers (Troponin-I or B-type natriuretic peptide). Mean RV:LV was 1.2±0.3 (range 0.7 to 2.8). Using logistic regression, higher RV:LV was associated with increased odds of death or CPR (odds ratio (OR) 15 [95% confidence interval (CI): 2.5, 82] per 1-unit increase, p=0.002. RV:LV >1.2 was the cutoff most associated with death or CPR, OR 7.2 [95% CI: 1.5, 34.5], p=0.01. Increasing RVD [OR 3.8 (95% CI: 1.1, 12.8), p=0.03] and decreasing LVD [OR 4.9 (95% CI: 1.3, 16.9), p=0.02] were independent predictors of death or CPR. RVD >5.0 cm (OR 5.9 [95% CI: 1,5, 23.2], p 0.01) and LVD <3.6 cm (OR 7.0 [95% CI: 1.7, 27.9], p=0.006) were the cutoff values most associated with the primary outcome. These cutoff values remained significant predictors even after adjustment for body surface area. Other parameters or RV size and function (diastolic area, systolic area and fractional area change) did not predict death or CPR. All of the subjects meeting the primary outcome had high-risk PE. Discussion: In addition to RV:LV greater than 1.2, RVD and LVD were independently associated with death or CPR among high- or intermediate risk PEs. The independent contribution of declining LVD on PE mortality is a novel finding and highlights PE associatient LV pathophysiology (hyperdynamic and underfilled) antecedent to hemodynamic collapse. PE literature focuses on RV dilation as a predictor of PE mortality. LVD may represent a useful measure to risk stratify PE patients and predict hemodynamic decompensation. Funding Acknowledgement: Type of funding sources: None.
- 1 January 2022
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 35 (1) , 77-85
Variations in Mitral Valve Leaflet and Scallop Anatomy on Three-Dimensional Transesophageal Echocardiography
- 1 January 2022
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 35 (1) , 77-85
Variations in Mitral Valve Leaflet and Scallop Anatomy on Three-Dimensional Transesophageal Echocardiography
- Open Access
- 21 March 2021
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (3) , 713-718
At what flow rate does aortic valve gradient become severely elevated? Implications for guideline recommendations on aortic valve area cutoffs
Introduction: Since many patients with AVA 40 mmHg, we sought to determine the AVA at which mAVG tends to exceed 40 mmHg in a sample of subjects with varied transvalvular flow rates. Material and methods: We selected 200 subjects with an AVA Results: The study sample was 79 ± 12...
- 21 March 2021
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 20 (3) , 713-718
Open AccessAt what flow rate does aortic valve gradient become severely elevated? Implications for guideline recommendations on aortic valve area cutoffs
Introduction: Since many patients with AVA 40 mmHg, we sought to determine the AVA at which mAVG tends to exceed 40 mmHg in a sample of subjects with varied transvalvular flow rates. Material and methods: We selected 200 subjects with an AVA Results: The study sample was 79 ± 12...
- Open Access
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 16 (1) , 66-70
Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
Introduction Several works have suggested heightened risk for cardiac events in cocaine users following percutaneous coronary intervention (PCI). Such studies have generally been performed in small, poorly defined samples and have not utilised optimal control groups. We aimed to define the...
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 16 (1) , 66-70
Open AccessHeightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
Introduction Several works have suggested heightened risk for cardiac events in cocaine users following percutaneous coronary intervention (PCI). Such studies have generally been performed in small, poorly defined samples and have not utilised optimal control groups. We aimed to define the...
- 1 January 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (1) , 3
Can the echocardiographic LV mass equation reliably demonstrate stable LV mass following acute change in LV load?
Background: Limited data are available on performance of the left ventricular (LV) mass equation when there is a dynamic change to LV load. We aimed to test this equation in the immediate post-operative period following aortic valve replacement (AVR) for aortic regurgitation (AR) to see if it would reliably demonstrate stable LV mass before and after surgery. Since LV mass would be unlikely to change in the immediate postoperative period, we hypothesized that a decrease in LV diameter postoperatively would be accompanied by concomitant increases in LV wall thickness as predicted by the LV mass equation. Methods: We reviewed echocardiograms of adult patients with AR who underwent AVR from 2007–2017 at Montefiore Medical Center (n=28). Three independent readers performed septal wall thickness (SWT), posterior wall thickness (PWT) and left ventricular internal diameter (LVID) measurements on pre-operative and post-operative echocardiograms. LV masses were calculated using the American Society of Echocardiography (ASE) equation. Results: Post-operatively, LVID decreased from 5.7±1.2 to 4.9±1.0 cm, PConclusions: Following aortic valve replacement for regurgitation, the LV mass equation calculated a reduction in LV mass in the immediate postoperative period. Since an immediate change in LV mass after AVR is unlikely, we feel that these results highlight an important limitation of the mass equation, when used with acutely changing loading conditions.
- 1 January 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (1) , 3
Can the echocardiographic LV mass equation reliably demonstrate stable LV mass following acute change in LV load?
Background: Limited data are available on performance of the left ventricular (LV) mass equation when there is a dynamic change to LV load. We aimed to test this equation in the immediate post-operative period following aortic valve replacement (AVR) for aortic regurgitation (AR) to see if it would reliably demonstrate stable LV mass before and after surgery. Since LV mass would be unlikely to change in the immediate postoperative period, we hypothesized that a decrease in LV diameter postoperatively would be accompanied by concomitant increases in LV wall thickness as predicted by the LV mass equation. Methods: We reviewed echocardiograms of adult patients with AR who underwent AVR from 2007–2017 at Montefiore Medical Center (n=28). Three independent readers performed septal wall thickness (SWT), posterior wall thickness (PWT) and left ventricular internal diameter (LVID) measurements on pre-operative and post-operative echocardiograms. LV masses were calculated using the American Society of Echocardiography (ASE) equation. Results: Post-operatively, LVID decreased from 5.7±1.2 to 4.9±1.0 cm, PConclusions: Following aortic valve replacement for regurgitation, the LV mass equation calculated a reduction in LV mass in the immediate postoperative period. Since an immediate change in LV mass after AVR is unlikely, we feel that these results highlight an important limitation of the mass equation, when used with acutely changing loading conditions.